id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0243-0003,FDA,FDA-2002-E-0243,Letter from FDA CDER to Sidley Austin Brown and Wood LPP,Rule,Certificate Extending Patent Term,2007-03-15T04:00:00Z,2007,3,,,2025-10-08T00:02:56Z,,0,0,090000648049a7ab
FDA-2002-E-0243-0002,FDA,FDA-2002-E-0243,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-11-24T05:00:00Z,2003,11,,,2025-10-08T00:01:14Z,,0,0,090000648049a7a8
FDA-2002-E-0243-0001,FDA,FDA-2002-E-0243,Determination of Regulatory Review Period for Purposes of Patent Extension; ZEVALIN,Notice,General Notice,2003-04-21T04:00:00Z,2003,4,2003-04-21T04:00:00Z,,2025-10-07T23:58:53Z,03-9694,0,0,090000648049a733